233: Impact-DCM: A Randomized, Controlled, Multi-Center Phase II Trial Utilizing Expanded Autologous Bone Marrow As Sole Therapy for Dilated Cardiomyopathy - Bruckner, B.A.; Bull, D.; Hammond, B.; Ali, G.; Elmar, B.; Matthias, L.; Michael, R.J.; Perryman, L.; Smedira, N.; Lattouf, O.; Bunge, R.R.; Patel, A. (Journal of Heart & Lung Transplantation, 2010)